VeraBIND Technology:
Revolutionizing Early Disease Detection
Transforming Diagnostic Accuracy with VeraBINDVeraBIND™ technology is at the forefront of early disease detection, particularly in challenging sample types. At its core, this innovative technology is designed to transform complex samples into matrix-free samples, significantly enhancing the performance of current market tests. It delivers unmatched precision in biomarker detection, empowering researchers and healthcare professionals to advance diagnostics and improve patient outcomes. VeraBIND is setting new standards in the field of biomarker enrichment and early disease detection.
Key Features of VeraBIND Technology
Uniform Size Magnetic Nanobeads
Improves reproducibility, precision, and binding capacity for more reliable results
Hydrophilic Surface Layer
Minimizes non-specific binding and increases the signal-to-noise ratio for accurate and sensitive test results
Rapid Magnetic Separation
Enables automation and reduces process times, enhancing laboratory efficiency
Improved Assay Accuracy
Pre-analytically cleans and conditions the sample to help improve the accuracy of assays that are challenged by interferences
Applications of VeraBIND Technology
Improving Diagnostic Accuracy
Enhances the precision of early disease detection, providing healthcare professionals with reliable data to make informed treatment and management decisions.
Facilitating Early Disease Detection
Supports early diagnostic tests to identify diseases at their initial stages, especially in conditions where early intervention can significantly alter the disease's progression.
Detecting Low-Abundance Biomarkers
Ideal for detecting subtle or scarce biomarkers, allowing researchers and clinicians to identify diseases at the earliest possible stage.
Accelerating Assay Development
Compatible with a wide range of established assays and detection methods, including ELISA, chemiluminescence, and mass spectrometry. VeraBIND integrates seamlessly with existing laboratory workflows, setting a new standard in biomarker discovery and assay development.
Advancing Personalized Medicine
Contributes to personalized medicine by identifying specific biomarkers, aiding in the development of tailored treatments for individual patients.
Enhancing Clinical Diagnostics & Research
Designed for clinical diagnostics and research, VeraBIND enables more sensitive detection of low abundance or previously undetectable biomarkers. Compatible with existing assays and various detection methods like ELISA, chemiluminescence, and mass spectrometry, VeraBIND sets a new standard in assay development and biomarker detection.
A Comprehensive Solution for Biomarker Detection
VeraBIND technology offers a unique and comprehensive approach, improving the accuracy of biomarker detection and reducing the incidence of false results. This groundbreaking innovation allows clinical laboratories to minimize assay interferences and refine their diagnostic processes, contributing significantly to early disease detection and enabling timely, targeted interventions.
VeraBIND was used to develop the VeraBIND Tau assay, a groundbreaking blood test for early detection of Alzheimer's Disease tau pathology. By eliminating interference from plasma samples and capturing and purifying biomarkers such as hyperphosphorylated tau (HPT), VeraBIND provides a more accurate and sensitive diagnostic approach. Our proprietary technology and product solutions makes Veravas a leader in non-invasive diagnostic solutions.